• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A miR-34a-SIRT6 axis in the squamous cell differentiation network.miR-34a-SIRT6 轴在鳞状细胞分化网络中的作用。
EMBO J. 2013 Aug 14;32(16):2248-63. doi: 10.1038/emboj.2013.156. Epub 2013 Jul 16.
2
miR-34a/SIRT6 in squamous differentiation and cancer.miR-34a/SIRT6在鳞状分化与癌症中的作用
Cell Cycle. 2014;13(7):1055-6. doi: 10.4161/cc.28378. Epub 2014 Feb 28.
3
MiR-34a-5p suppresses cutaneous squamous cell carcinoma progression by targeting SIRT6.miR-34a-5p 通过靶向 SIRT6 抑制皮肤鳞状细胞癌的进展。
Arch Dermatol Res. 2024 May 31;316(6):299. doi: 10.1007/s00403-024-03106-w.
4
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.SIRT1 抑制可恢复 p53 突变的人角质形成细胞的凋亡敏感性。
Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288-97. doi: 10.1016/j.taap.2014.04.001. Epub 2014 Apr 12.
5
MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.microRNA-34a 通过下调 SIRT1 和上调 p53 蛋白在野生型 p53 基因背景下人食管鳞状癌细胞中诱导类似衰老的变化。
Cancer Lett. 2016 Jan 28;370(2):216-21. doi: 10.1016/j.canlet.2015.10.023. Epub 2015 Oct 30.
6
miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.微小RNA-34a通过靶向沉默调节蛋白6抑制非小细胞肺癌的肿瘤发生。
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1135-1145. eCollection 2018.
7
SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.SIRT1调节p53突变的人角质形成细胞中的微小RNA加工缺陷。
J Dermatol Sci. 2014 May;74(2):142-9. doi: 10.1016/j.jdermsci.2014.01.008. Epub 2014 Jan 31.
8
Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.miR-34a和miR-143的下调可能间接抑制口腔鳞状细胞癌中的p53:一项初步研究。
Asian Pac J Cancer Prev. 2015;16(17):7619-25. doi: 10.7314/apjcp.2015.16.17.7619.
9
WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.WNT1 是 miR-34a 的一个靶标,通过 WNT/β-catenin 通路诱导 E-P 钙黏附蛋白转换,促进宫颈鳞癌细胞的增殖和侵袭。
Cell Oncol (Dordr). 2020 Jun;43(3):489-503. doi: 10.1007/s13402-020-00506-8. Epub 2020 Apr 16.
10
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.miR-34a对前列腺癌PC3细胞生长和化疗耐药性的影响。
Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.

引用本文的文献

1
Sperm abnormality: Differential expression of microRNAs.精子异常:微小RNA的差异表达
J Assist Reprod Genet. 2025 Jun 30. doi: 10.1007/s10815-025-03562-x.
2
The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia-A Promising Road Ahead.沉默调节蛋白家族组蛋白去乙酰化酶在急性髓系白血病中的作用——前路光明。
Cancers (Basel). 2025 Mar 17;17(6):1009. doi: 10.3390/cancers17061009.
3
Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma.血清来源的细胞外囊泡在血管肉瘤中的新型检测及临床应用
Acta Derm Venereol. 2025 Feb 25;105:adv40902. doi: 10.2340/actadv.v105.40902.
4
Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats.通过系统给予辣椒素促进骨愈合:Wistar 大鼠的实验研究。
Med Sci Monit. 2024 May 30;30:e942485. doi: 10.12659/MSM.942485.
5
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.靶向头颈部鳞状细胞癌中的组蛋白去乙酰化酶:分子机制和治疗靶点。
J Transl Med. 2024 May 3;22(1):418. doi: 10.1186/s12967-024-05169-9.
6
Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌中沉默调节蛋白 6(SIRT6)的表达分析和生物学调控。
An Bras Dermatol. 2024 Jul-Aug;99(4):535-545. doi: 10.1016/j.abd.2023.08.010. Epub 2024 Mar 27.
7
The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease.Sirtuin 6 在组蛋白去乙酰化中的作用作为肿瘤疾病进展的一个因素。
Int J Mol Sci. 2023 Dec 29;25(1):497. doi: 10.3390/ijms25010497.
8
The roles of sirtuins in ferroptosis.沉默调节蛋白在铁死亡中的作用。
Front Physiol. 2023 Apr 20;14:1131201. doi: 10.3389/fphys.2023.1131201. eCollection 2023.
9
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.靶向去乙酰化酶SIRT6揭示了剪接体失调是侵袭性骨髓瘤可利用的弱点。
Blood Adv. 2023 Jul 25;7(14):3472-3478. doi: 10.1182/bloodadvances.2022009035.
10
The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region.miRNA-221 和 miRNA-34a 在头颈部非黑素瘤皮肤癌中的作用。
Genes (Basel). 2023 Feb 16;14(2):503. doi: 10.3390/genes14020503.

本文引用的文献

1
A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.微小 RNA miR-34a 调控的双模态开关靶向结肠癌干细胞中的 Notch。
Cell Stem Cell. 2013 May 2;12(5):602-15. doi: 10.1016/j.stem.2013.03.002.
2
On measuring miRNAs after transient transfection of mimics or antisense inhibitors.关于测量转染 mimic 或反义抑制剂后 miRNA 的表达。
PLoS One. 2013;8(1):e55214. doi: 10.1371/journal.pone.0055214. Epub 2013 Jan 24.
3
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.组蛋白去乙酰化酶 SIRT6 是一种肿瘤抑制因子,可控制癌症代谢。
Cell. 2012 Dec 7;151(6):1185-99. doi: 10.1016/j.cell.2012.10.047.
4
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome.p63 控制桥粒基因表达和黏附的功能在 AEC 综合征中受损。
Hum Mol Genet. 2013 Feb 1;22(3):531-43. doi: 10.1093/hmg/dds464. Epub 2012 Oct 29.
5
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.NAD+依赖的组蛋白去乙酰化酶 SIRT6 通过调节 Ca2+ 反应促进胰腺癌细胞中的细胞因子产生和迁移。
J Biol Chem. 2012 Nov 30;287(49):40924-37. doi: 10.1074/jbc.M112.405837. Epub 2012 Oct 18.
6
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.肝癌的发生是由 AP-1 通过 SIRT6 依赖的抑制生存素来控制的。
Nat Cell Biol. 2012 Nov;14(11):1203-11. doi: 10.1038/ncb2590. Epub 2012 Oct 7.
7
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.TGF-β-miR-34a-CCL22 信号诱导 Treg 细胞募集促进 HBV 阳性肝细胞癌的静脉转移。
Cancer Cell. 2012 Sep 11;22(3):291-303. doi: 10.1016/j.ccr.2012.07.023.
8
miR-34 - a microRNA replacement therapy is headed to the clinic.miR-34——一种微小RNA替代疗法即将进入临床应用。
Front Genet. 2012 Jul 2;3:120. doi: 10.3389/fgene.2012.00120. eCollection 2012.
9
MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.微小 RNA-125b 下调基质金属蛋白酶 13,抑制皮肤鳞状细胞癌细胞增殖、迁移和侵袭。
J Biol Chem. 2012 Aug 24;287(35):29899-908. doi: 10.1074/jbc.M112.391243. Epub 2012 Jul 10.
10
Induction of specific microRNAs inhibits cutaneous wound healing.诱导特定的 microRNAs 会抑制皮肤伤口愈合。
J Biol Chem. 2012 Aug 24;287(35):29324-35. doi: 10.1074/jbc.M112.382135. Epub 2012 Jul 6.

miR-34a-SIRT6 轴在鳞状细胞分化网络中的作用。

A miR-34a-SIRT6 axis in the squamous cell differentiation network.

机构信息

Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.

出版信息

EMBO J. 2013 Aug 14;32(16):2248-63. doi: 10.1038/emboj.2013.156. Epub 2013 Jul 16.

DOI:10.1038/emboj.2013.156
PMID:23860128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3746195/
Abstract

Squamous cell carcinomas (SCCs) are highly heterogeneous tumours, resulting from deranged expression of genes involved in squamous cell differentiation. Here we report that microRNA-34a (miR-34a) functions as a novel node in the squamous cell differentiation network, with SIRT6 as a critical target. miR-34a expression increases with keratinocyte differentiation, while it is suppressed in skin and oral SCCs, SCC cell lines, and aberrantly differentiating primary human keratinocytes (HKCs). Expression of this miRNA is restored in SCC cells, in parallel with differentiation, by reversion of genomic DNA methylation or wild-type p53 expression. In normal HKCs, the pro-differentiation effects of increased p53 activity or UVB exposure are miR-34a-dependent, and increased miR-34a levels are sufficient to induce differentiation of these cells both in vitro and in vivo. SIRT6, a sirtuin family member not previously connected with miR-34a function, is a direct target of this miRNA in HKCs, and SIRT6 down-modulation is sufficient to reproduce the miR-34a pro-differentiation effects. The findings are of likely biological significance, as SIRT6 is oppositely expressed to miR-34a in normal keratinocytes and keratinocyte-derived tumours.

摘要

鳞状细胞癌(SCCs)是高度异质性的肿瘤,源于参与鳞状细胞分化的基因表达失调。在这里,我们报告 miR-34a(miR-34a)作为鳞状细胞分化网络中的一个新节点,SIRT6 是一个关键靶点。miR-34a 的表达随着角质形成细胞的分化而增加,而在皮肤和口腔 SCCs、SCC 细胞系和异常分化的原代人角质形成细胞(HKCs)中则受到抑制。通过逆转基因组 DNA 甲基化或野生型 p53 表达,可在 SCC 细胞中恢复该 miRNA 的表达,同时伴随分化。在正常的 HKCs 中,增加的 p53 活性或 UVB 暴露的促分化作用依赖于 miR-34a,并且增加的 miR-34a 水平足以诱导这些细胞在体外和体内分化。SIRT6 是先前与 miR-34a 功能无关的 Sirtuin 家族成员,是该 miRNA 在 HKCs 中的直接靶标,下调 SIRT6 足以再现 miR-34a 的促分化作用。这些发现具有重要的生物学意义,因为 SIRT6 在正常角质形成细胞和角质形成细胞来源的肿瘤中与 miR-34a 的表达相反。